Why the study?
Impairment of the coronary microcirculation is increasingly recognized as a cause of ischemic heart disease, but its pathogenesis is complex and specific therapies targeting coronary microvascular dysfunction are lacking.
Design
Review
Loading...
Raises clinician awareness of coronary microvascular dysfunction across diseases; extends mechanistic synthesis but leaves therapeutic trials open.
Key points are not available for this paper at this time.
A 2021 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: